Sitemap
JPB 로고The Korean Society of Plant Biotechnology｜Contact Us
닫기
Search
Advanced Search +
닫기
Quick links
Most Cited Most Read Archives Go to e-Submission

Research Article

Split Viewer

J Plant Biotechnol (2023) 50:027-033

Published online March 29, 2023

https://doi.org/10.5010/JPB.2023.50.004.027

© The Korean Society of Plant Biotechnology

UHPLC/TOFHRMS analysis and anti-inflammatory effect of leaf extracts from Zizyphus jujuba in LPS-stimulated RAW264.7 cells

Hyun Ji Eo ･Sun-Young Lee ･Gwang Hun Park

Author Info. +

Special Forest Resources Division, Department of Forest Bio-Resources, National Institute of Forest Science, Suwon 16631, Korea
Forest Medicinal Resources Research Center, National Institute of Forest Science, Yeongju 36040, Korea
Forest Medicinal Resources Research Center, National Institute of Forest Science, Yeongju 36040, Korea

Correspondence to : e-mail: ppkh0230@korea.kr

Received: 1 November 2022; Revised: 9 February 2023; Accepted: 10 February 2023

This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Go to

Zizyphus jujube is a plant in the buckthorn family (Rhamnaceae) that has been the subject of research into antibacterial, antifungal and anti-inflammatory properties of its fruit and seed. However, few studies have investigated its leaves. In this study, the anti-inflammatory activity of ZJL (an extract of Z. jujube leaf) was evaluated to verify its potential as an anti-inflammatory agent and SARS-CoV-2 medicine, using nitric oxide (NO) assay, RT-PCR, SDS-PAGE, Western blotting, and UHPLC/TOFHRMS analysis. We found that ZJL suppresed pro-inflammatory mediators such as NO, inducible nitric oxide synthase (iNOS), cyclooxy-genase-2 (COX-2), and tumor necrosis factor α (TNF-α) in lipopolysaccharide (LPS)-induced RAW264.7 cells. ZJL acted by inhibiting NF-KB and MAPK signaling pathway activity. We also confirmed that ZJL contains a phenol compound and flavonoids with anti-inflammatory activity such as trehalose, maleate, epigallocatechin, hyperoside, catechin, 3-O-coumaroylquinic acid, rhoifolin, gossypin, kaempferol 3-neohesperidoside, rutin, myricitrin, guaiaverin, quercitrin, quercetin, ursolic acid, and pheophorbide a. These findings suggest that ZJL may have great potential for the development of anti-inflammatory drugs and vaccines via inhibition of NF‐ĸB and MAPK signaling in LPS-induced RAW264.7 cells.

Keywords Anti-inflammation, MAPK, NF-κB, UHPLC/TOFHRMS, Ziziphus jujuba

Introduction

Go to

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) first emerged in Wuhan, China in December 2019. It is a type of highly pathogenic human coronavirus (HCoV) that poses a major threat to public health and causes disease in animals. Most coronavirus disease 2019 (COVID-19) patients had a good prognosis, but there were still some serious illnesses and deaths. One of the key features of COVID-19 is excessive inflammation observed in some patients, particularly those with severe illness. An exaggerated immune response mediated by a series of cytokines plays a key role in the development of disease. Studies have reported that several types of inflammatory mediators and immune cells are involved in the disease process (Saeedi-Boroujeni and Mahmoudian-Sani 2021; Zabetakis et al. 2020). The health status of our industrial population is at risk due to numerous inflammatory chronic diseases characterized by widespread and potentially low-grade inflammation. Therefore, researchers around the world have explored several anti-inflammatory and other pharmacological treatments to combat deadly inflammation (Tasinov et al. 2021; Tay et al. 2020).

Zizyphus jujuba Mill is one of the most important plants of the Rhamnaceae family (Ghani et al. 2022). Z. jujuba is a small deciduous tree that occurs naturally in Europe, East Asia and Australia. Many studies have been reported on jujube fruit and seed preparations that have been stimulated by their long-term use in Chinese and Korean traditional medicine for their antibacterial, antifungal, anti-inflammatory, antioxidant activity and anticancer properties (Damiano et al. 2017). Z. jujuba contains a wide range of constituents, including flavonoids such as quercetin, rutin, isoquercitrin, nicotiflorine and kaempferol, phenolic acid, triterepenoic acid and amino acids (Hong et al. 2015; Lee et al. 2004; Lee et al. 2016).

In this study, we evaluated the anti-inflammatory effect of Z. jujuba leaf in LPS-induced RAW264.7 cells and identified the regulatory mechanisms of NF-κB (nuclear factor kappa B) and MAPK (mitogen activated protein kinase) as molecular targets. In addition, by analyzing the components of Z. jujuba leaf, we tried to evaluate the possibility of using them as anti-inflammatory agents.

Materials and Methods

Go to

Materials

As a medium for culturing mouse macrophages (RAW264.7 cells), Dulbecco’s Modified Eagle’s medium (DMEM) was purchased from Lonza (Walkersville, MD, USA). Griess reagent used for detection and quantification of nitrite and nitrite ion and Thiazolyl Blue Tetrazolium Blue (MTT) for cytotoxicity evaluation and lipopolysaccharide (LPS) for anti-inflammatory evaluation were purchased from Sigma-Aldrich (St. Louis, MO, USA). Antibodies for western blot were purchased from Cell Signaling Technology (Danvers, MA, USA).

Preparation of extracts

Z. jujuba leaf (ZJL) was collected in June 2019 in Andong-si, Gyeongsangbuk-do, Korea, and were identified by Professor Jeong Kyu-young, Andong University (voucher number. FMRC-2190621A1). 20 g of freeze-dried ZJL was extracted with 100 mL of 70% ethanol (70% EtOH) for 48 hours while stirring at room temperature. After 48 hours, the 70% EtOH extract was filtered, concentrated using a vacuum evaporator (N-1000, EYELA, Tokyo, Japan), and then freeze-dried (recovery rate after sample extraction: 55.6 ± 4.1%). ZJL extract was dissolved in dimethyl sulfoxide (DMSO) and used in the experiments.

Cell culture

RAW264.7 cells were adopted from the American Type Culture Collection (ATCC, Virginia, USA). RAW264.7 cells were cultured in DMEM medium supplemented with 10% fetal bovine serum (FBS) at 37°C and 5% CO2. Cells were treated with ZJL dissolved in DMSO used as a vehicle at a final concentration of less than 0.1% (v/v).

MTT assay

RAW264.7 cells (1 × 106 cells/well) cultured in a 12-well plate were treated with ZJL for 24 hours. After 24 hours, 200 μL of MTT solution (1 mg/mL) was added and incubated for 2 hours. After 2 hours, the medium was removed and DMSO was added to the cells. The absorbance of the solution dissolved by DMSO was measured at 570 nm using a UV/visible spectrophotometer (Perkin Elmer, Norwolk, CT, USA).

Nitric oxide (NO) assay

RAW264.7 cells cultured in a 12-well plate (1 × 106 cells/well) for 24 hours were pretreated with ZJL for 6 hours. After 6 hours, RAW264.7 cells were co-treated with LPS (1 μg/mL) for 18 hours to induce an inflammatory response. After 18 hours, 50 μL of cell medium and 50 μL of Griess reagent were mixed in a 1:1 ratio. After reacting at room temperature for 10 minutes, absorbance was measured with a UV/Visible spectrophotometer 540 nm (Perkin Elmer, Norwalk, Connecticut, USA).

Sodium Dodecyl Sulfate-Poly Acrylamide Gel Electrophoresis (SDS-PAGE) and Western blot

After the experiment, RAW264.7 cells were harvested after washing three times with cold 1X phosphate buffered saline (1XPBS). RAW264.7 cells were lysed in 1X radioimmunoprecipitation assay (RIPA) buffer (Cell signaling, Bervely, MA, USA) and centrifuged at 15,000 rpm for 10 minutes at 4°C. Cellular protein was quantified using BCA protein assay (Thermo Fisher Scientific, Waltham, MA USA). Proteins separated by SDS-PAGE were transferred to a nitrocellulose membrane (Bio-Rad, CA, USA). After 1 hour of blocking (5% skim milk), the membrane was treated with primary antibody (1:1000) overnight. After overnight, they were washed three times with 0.05% Tween 20 and treated with secondary antibody (1:200) for 1 hour at room temperature. After ECL Western blotting was applied to the membrane, it was analyzed using the Chemi Doc MP Imaging system (Bio-rad, CA, USA).

Reverse transcriptase-polymerase chain reaction (RT-PCR)

RNeasy Mini Kit (Qiagen, Valencia, CA, USA) was used to extract total RNA from RAW264.7 cells after the experiment. To synthesize cDNA, 1 μg of total RNA was processed with the Verso cDNA synthesis kit. After cDNA synthesis, PCR was performed using a PCR master mix kit (Promega Co., Madison, WI, USA). Primers used for PCR (mouse iNOS, mouse COX-2, mouse TNF-α and mouse GAPDH) are listed in Table 1.

Table 1 Sequences of oligonucleotide primers used for RT-PCR

NO.Gene nameSequence
1iNOSForward 5′-GTG CTG CCT CTG GTC TTG CAA GC-3′
Reverse 5′-AGG GGC AGG CTG GGA ATT CG-3′
2COX-2Forward 5′-GGA GAG ACT ATC AAG ATA GTG ATC -3′
Reverse 5′-ATG GTC AGT AGA CTT TTA CAG CTC -3′
3TNF-αForward 5’-TAC TGA ACT TCG GGG TGA TTG GTC C-3’
Reverse 5’-CAG CCT TGT CCC TTG AAG AGA ACC-3’
4GAPDHForward 5′-CAG GAG CGA GAC CCC ACT AAC AT-3′
Reverse 5′-GTC AGA TCC ACG ACG GAC ACA TT-3′


Ultra-high performance liquid-chromatography/time-of-flight high-resolution mass spectrometry (UHPLC/TOFHRMS) analysis

UHPLC instrument (Therom Dionex, USA) equipped with a Waters Cortect C18 (2.1 mm × 150 mm, 1.8 μm, Water, USA) column was used. 0.1% Formic acid in water (A) and 0.1% Formic acid in acetonitrile (B) were used as mobile phase at a flow rate of 0.3 mL/min. The system was run with the following gradient program: 1% B for 1 min, 1%-30% B for 1-13 min, 21%-100% B for 13-21 min, maintained until the 24th min, 100%-1% B for 24-25 min, and maintained until the 30 min. The temperature of the column was maintained at 45 °C, and the injection volume was 3 μL.

Statistical analysis

All results were expressed as mean ± standard deviation after repeated measurements three times, and significance between treatments was verified by Student’s t-test. When p-value < 0.05, it was determined to be statistically significant.

Results and Discussion

Go to

The effect of ZJL on NO production and cytokines expression in LPS-stimulated RAW264.7 cells

COVID-19 infection is associated with an aggressive inflammatory response that releases large amounts of proinflammatory cytokines in an event known as a “cytokine storm.” The host immune response to the SARS-CoV-2 virus is hyperactive, resulting in an excessive inflammatory response (Ragab et al. 2020). Therefore, suppression of excessive cytokines such as iNOS, COX-2, and TNF-α is the key to anti-inflammatory effect. The effect of ZJL on the inhibition of NO production in LPS-induced RAW264.7 cells was investigated. MTT assay showed that ZJL (0, 12.5, 25, 50 μg/ml) was not toxic to RAW264.7 cells (Fig. 1A). As shown in Fig. 1B, ZJL reduced LPS-induced excessive production of NO in RAW264.7 cells in a concentration dependent manner (0, 12.5, 25, 50 μg/ml). Therefore, macrophages are RAW264.7 cells stimulated with LPS to confirm the inhibitory activity of inflammatory mediator gene expression, such as iNOS, COX-2, and TNF-α, which are known to be involved in the pathogenesis of inflammatory diseases. In Fig. 1C, it was confirmed that ZJL decreased the expression of iNOS, COX-2 and TNF-α in a concentration-dependent manner as affecting the expression of inflammatory derivatives. From these results, it was confirmed that ZJL can exhibit anti-inflammatory activity.

Fig. 1. Effect of ZJL on the NO production of pro-inflammatory mediators such as iNOS, COX-2 and TNF-α in LPS-stimulated RAW264.7 cells. (A) RAW264.7 cells were treated with 25, 50, 100 μg/ml of ZJL for 24 hours, then an MTT assay was performed. (B) RAW264.7 cells were pretreated with 25, 50, 100 μg/ml of ZJL for 6 hours, then co-treated with 1 μg/mL of LPS for 18 hours, and then a Griess assay was performed. (C) RT-PCR analysis of total RNA. GAPDH was used as an internal control. *: significant difference (P < 0.05) to cells without ZJL

Effect of ZJL on NF-κB signaling activation in LPS-stimulated RAW264.7 cells

The basic mechanism of NF-κB activation is the inducible degradation of IκBα triggered by the multisubunit IκB kinase (IKK) complex. IKKs can be activated by cytokines, mitogens, microbial components, growth factors and infectious agents. Upon stimulation, NF-κB induces the expression of various pro-inflammatory cytokine genes. These pro-inflammatory cytokines further activate NF-κB signaling in an autocrine manner. SARS-CoV-2 appears to activate NF-κB and produce proinflammatory cytokines that correlate with mechanisms of COVID-19 pathogenesis. Because pro-inflammatory cytokines are elevated in patients with severe COVID-19. Indeed, NF-κB is activated in SARS-CoV-2 infected cells (Kircheis et al. 2020; Su et al. 2021). Therefore, in order to examine the effect of ZJL on the inhibition of NF-κB activity, it was confirmed that when LPS-derived RAW264.7 cells were treated with ZJL, IκB phosphorylation and degradation were inhibited in a concentration-dependent manner (Fig. 2A and B). As shown in 2C, it was confirmed that ZJL inhibits nuclear translocation of p65. These results suggest that ZJL has an anti-inflammatory effect by inhibiting NF-κB activity.

Fig. 2. Effects of ZJL on NF-κB signaling activation in LPS-stimulated RAW264.7 cells. (A, B) RAW264.7 cells were pretreated with ZJL (0, 25, 50 μg/mL) for 6 hours and then co-treated with LPS (1 μg/mL) for 40 min. (C) RAW264.7 cells were pre-treated with ZJL (0, 25, 50 μg/mL) for 40 min. After the treatment, the cytosol and nucleus were prepared. For Western blot analysis, cell lysates were subjected to SDS-PAGE and the Western blot was performed using antibodies against IκB-α, p-IκB-α and nucleus p65. β-actin was used as an internal control. #: signficant difference (P < 0.05) to cells without treatment; *: significant difference (P < 0.05) to cells treated with LPS only

Effect of ZJL on MAPKs signaling activation in LPS-stimulated RAW264.7 cells

Several investigations have concluded that SARS-CoV-2 is a major factor in the increased cytokine inflammatory response associated with COVID-19 through activation of MAPK/NF-κB signaling. Elevated MAPKs signaling pathways including proteins such as extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK) and p38 control p65/NF-activation for cytokine production (Hariharan et al. 2021; Sharma et al. 2022; Ye et al. 2020). We investigated whether ZJL inhibits phosphorylation of ERK1/2, p38 or JNK, elucidating the inhibitory effect of ZJL on MAPKs signaling activation in LPS-induced RAW264.7 cells. Phosphorylation of ERK1/2 was inhibited in a concentration dependent manner (Fig. 3A). As shown in Fig. 3B, it was confirmed that ZJL inhibits p38 phosphorylation. JNK phosphorylation was inhibited in a concentration-dependent manner (12.5, 25, and 50 μg/ml). ZJL demonstrated anti-inflammatory potential in LPS-induced RAW264.7 cells by downregulating the MAPKs signaling pathway.

Fig. 3. Effects of ZJL on MAPKs signaling activation in LPS-stimulated RAW264.7 cells. RAW264.7 cells were pretreated with ZJL (0, 25, 50 μg/mL) for 6 h and then co-treated with LPS (1 μg/mL) for 40 min. For Western blot analysis, the cell lysates were subjected to SDS-PAGE and the Western blot was performed using antibodies against p-p38, p-ERK1/2, and p-JNK. #: significant difference (P < 0.05) to cells without treatment; *: significant difference (P < 0.05) to cells treated with LPS only

HUPLC/TOFHRMS analysis of anti-inflammatory compounds in ZJL

To analyze the bioactive compounds with anti-inflammatory activity from ZJL, we performed HUPLC/TOFHRMS analysis. As shown in Table 2, ZJL was analyzed to contain compounds such as trehalose (Echigo et al. 2012), maleate (Vijeesh et al. 2022), epigallocatechin (Wu et al. 2017), hyperoside (Kim et al. 2011), catechin (Fan et al. 2017; Kim and Heo, 2022), 3-O-coumaroylquinic acid, rhoifolin (Eldahshan and Azab, 2012; Peng et al. 2020), gossypin (Cinar et al. 2019), kaempferol 3-neohesperidoside (Zanatta et al. 2008), rutin (Guardia et al. 2001), myricitrin (Domitrović et al. 2015), guaiaverin (Comalada et al. 2005; Tasinov et al. 2021), quercitrin (Lee et al. 2016), quercetin (Tang et al. 2019), ursolic acid (Checker et al. 2012) and phephorbide a (Nakamura et al. 1996) by UHPLC/MSMS. The compounds have been reported to anti-inflammatory activity.

Table 2 Results of UHPLC/HRMS analysis of 16 functional components in ZJL

NO.Retention time (min)ChemicalMolecular formulaMolecular weight
11.16TrehaloseC12H14O6342.1
21.2MaleateC4H4O4116
36.85EpigallocatechinC15H14O7306.1
46.93HyperosideC21H20O12464.1
57.14CatechinC15H14O6290.1
68.493-O-Coumaroylquinic acidC16H18O8338.1
78.5RhoifolinC27H30O14578.2
89.59GossypinC21H20O13480.1
910.11Kaempferol 3-neohesperidosideC27H30O1510.11
1010.37RutinC27H30O16610.2
1110.47MyricitrinC21H20O12464.1
1211.22GuaiaverinC20H18O11434.1
1311.67QuercitrinC21H20O11448.1
1414.19QuercetinC15H10O7302
1521.78Ursolic acidC30H48O3456.4
1622.58Pheophorbide aC35H36N4592.3


In conclusion, these results suggest that ZJL can be used as an alternative supplement for anti-inflammatory and COVID-19 treatment (vaccine). Isolation of anti-inflammatory substances and identification of mechanisms are considered necessary in the future.

Acknowledgement

Go to

This work was supported by a grant from National Institute of Forest Science (project number: FP0400-2019-01-2022).

REFERENCES

Go to
  1. Checker R, Sandur SK, Sharma D, Patwardhan RS, Jayakumar S, Kohli V, Sethi G, Aggarwal BB, Sainis KB (2012) Potent Anti-Inflammatory Activity of Ursolic Acid, a Triterpenoid Antioxidant, Is Mediated through Suppression of NF-κB, AP-1 and NF-AT. PLOS ONE 7(2):e31318. https://doi.org/10.1371/journal.pone.0031318
    Pubmed KoreaMed CrossRef
  2. Cinar I, Sirin B, Aydin P, Toktay E, Cadirci E, Halici I, Halici Z (2019) Ameliorative effect of gossypin against acute lung injury in experimental sepsis model of rats. Life Sci 221:327-334. doi: 10.1016/j.lfs.2019.02.039
    Pubmed CrossRef
  3. Comalada M, Camuesco D, Sierra S, Ballester I, Xaus J, Gálvez J, Zarzuelo A (2005) In vivo quercitrin anti-inflammatory effect involves release of quercetin, which inhibits inflammation through down-regulation of the NF-kappaB pathway. Eur J Immunol 35(2):584-592. doi: 10.1002/eji.200425778
    Pubmed CrossRef
  4. Damiano S, Forino M, De A, Vitali LA, Lupidi G, Taglialatela-Scafati O (2017) Antioxidant and antibiofilm activities of secondary metabolites from Ziziphus jujuba leaves used for infusion preparation. Food Chemistry 230:24-29
    Pubmed CrossRef
  5. Domitrović R, Rashed K, Cvijanović O, Vladimir-Knežević S, Škoda M, Višnić A (2015) Myricitrin exhibits antioxidant, anti-inflammatory and antifibrotic activity in carbon tetrachloride-intoxicated mice. Chem Biol Interact 230:21-29. doi: 10.1016/j.cbi.2015.01.030
    Pubmed CrossRef
  6. Echigo R, Shimohata N, Karatsu K, Yano F, Kayasuga-Kariya Y, Fujisawa A, Ohto T, Kita Y, Nakamura M, Suzuki S, Mochizuki M, Shimizu T, Chung UI, Sasaki N (2012) Trehalose treatment suppresses inflammation, oxidative stress, and vasospasm induced by experimental subarachnoid hemorrhage. J Transl Med 10:80. doi: 10.1186/1479-5876-10-80
    Pubmed KoreaMed CrossRef
  7. Eldahshan OA, Azab SS (2012) Anti-inflammatory Effect of Apigenin-7-neohesperidoside (Rhoifolin) in Carrageenin-Induced Rat Oedema Model. Journal of Applied Pharmaceutical Science 2(8):74-79. doi: 10.7324/JAPS.2012.2811
    CrossRef
  8. Fan FY, Sang LX, Jiang M (2017) Catechins and Their Therapeutic Benefits to Inflammatory Bowel Disease. Molecules 22(3):484. doi: 10.3390/molecules22030484
    Pubmed KoreaMed CrossRef
  9. Ghani A, Amini S, Mohtashami S, Neamati SH (2022) Physicochemical and biochemical variations of jujube (Ziziphus jujuba Mill.) populations: A comparison of Iranian and imported types. Industrial Crops & Products 183:114898
    CrossRef
  10. Guardia T, Rotelli AE, Juarez AO, Pelzer LE (2001) Anti-inflammatory properties of plant flavonoids. Effects of rutin, quercetin and hesperidin on adjuvant arthritis in rat. Il Farmaco 56(9):683-687. https://doi.org/10.1016/S0014-827X(01)01111-9
    Pubmed CrossRef
  11. Hariharan A, Hakeem AR, Radhakrishnan S, Reddy MS, Rela M (2021) The role and therapeutic potential of nf-kappa-b pathway in severe COVID-19 patients. Inflammopharmacology 29:91-100. DOI: 10.1007/s10787-020-00773-9
    Pubmed KoreaMed CrossRef
  12. Hong EH, Song JH, Kang KB, Sung SH, Ko HJ, Yang HJ (2015) Anti-Influenza Activity of Betulinic Acid from Zizyphus jujuba on Influenza A/PR/8 Virus. Biomolecules & Therapeutics 23(4):345-349
    CrossRef
  13. Kim JM, Heo HJ (2022) The roles of catechins in regulation of systemic inflammation. Food Sci Biotechnol. https://doi.org/10.1007/s10068-022-01069-0
    Pubmed KoreaMed CrossRef
  14. Kim SJ, Um JY, Lee JY (2011) Anti-inflammatory activity of hyperoside through the suppression of nuclear factor-κB activation in mouse peritoneal macrophages. Am J Chin Med 39(1):171-181. DOI: 10.1142/S0192415X11008737
    Pubmed CrossRef
  15. Kircheis R, Haasbach E, Lueftenegger D, Heyken WT, Ocker M, Planz O (2020) KNF-κB Pathway as a Potential Target for Treatment of Critical Stage COVID-19 Patients. Front Immunol 11:598444. https://doi.org/10.3389/fimmu.2020.598444
    Pubmed KoreaMed CrossRef
  16. Lee JS, Choi JW, Sohng JK, Pandey RP, Park YI (2016) The immunostimulating activity of quercetin 3-O-xyloside in murine macrophages via activation of the ASK1/MAPK/NF-κB signaling pathway. International Immunopharmacology 31:88-97
    Pubmed CrossRef
  17. Lee SM, Park JG, Lee YH, Lee CG, Min BS, Kim JH, Lee HK (2004) Anti-complementary Activity of Triterpenoides from Fruits of Zizyphus jujuba. Biol Pharm Bull 27(11):1883-1886
    Pubmed CrossRef
  18. Nakamura Y, Murakami A, Koshimizu K, Ohigashi H (1996) Inhibitory effect of pheophorbide a, a chlorophyll-related compound, on skin tumor promotion in ICR mouse. Cancer Letters 108(2):247-255
    CrossRef
  19. Peng S, Hu C, Liu X, Lei L, He G, Xiong C, Wu W (2020) Rhoifolin regulates oxidative stress and proinflammatory cytokine levels in Freund's adjuvant-induced rheumatoid arthritis via inhibition of NF-κB. Braz J Med Biol Res 53(6):9489. doi: 10.1590/1414-431X20209489
    Pubmed KoreaMed CrossRef
  20. Ragab D, Eldin HS, Taeimah M, Khattab R, Salem R (2020) The COVID-19 Cytokine Storm; What We Know So Far. Frontiers in Immunology 11:1446. https://doi.org/10.3389/fimmu.2020.01446
    Pubmed KoreaMed CrossRef
  21. Saeedi-Boroujeni A, Mahmoudian-Sani MR (2021) Anti-inflammatory potential of Quercetin in COVID-19 treatment. Journal of Inflammation 18(3):1-9
    Pubmed KoreaMed CrossRef
  22. Sharma VK, Prateeksha, Singh SP, Singh BN, Rao CV, Barik SK (2022) Nanocurcumin Potently Inhibits SARS-CoV-2 Spike Protein-Induced Cytokine Storm by Deactivation of MAPK/NF-κB Signaling in Epithelial Cells. ACS Appl Bio Mater 5(2):483-491. https://doi.org/10.1021/acsabm.1c00874
    Pubmed KoreaMed CrossRef
  23. Su CM, Wang L, Yoo D (2021) Activation of NF-κB and induction of proinflammatory cytokine expressions mediated by ORF7a protein of SARS-CoV-2. scientific reports 11:13464. https://doi.org/10.1038/s41598-021-92941-2
    Pubmed KoreaMed CrossRef
  24. Tang J, Diao P, Shu X, Li L, Xiong L (2019) Quercetin and Quercitrin Attenuates the Inflammatory Response and Oxidative Stress in LPS-Induced RAW264.7 Cells: In Vitro Assessment and a Theoretical Model. BioMed Research International 2019:7039802. https://doi.org/10.1155/2019/7039802
    Pubmed KoreaMed CrossRef
  25. Tasinov O, Dincheva I, Badjakov I, Kiselova-Kaneva Y, Galunska B, Nogueiras R, Ivanova D (2021) Phytochemical Composition, Anti-Inflammatory and ER Stress-Reducing Potential of Sambucus ebulus L. Fruit Extract Plants (Basel) 10(11):2446. doi: 10.3390/plants10112446
    Pubmed KoreaMed CrossRef
  26. Tay M, Poh C, Renia L, MacAry P, Ng L (2020) The trinity of COVID-19: Immunity, inflammation and intervention. Nature Reviews Immunology 20:363-374
    Pubmed KoreaMed CrossRef
  27. Vijeesh V, Vysakh A, Jisha N, Latha MS (2022) Malic Acid Attenuates Potassium Oxonate Induced Gouty Inflammation in Wistar Rat. Biointerface Research in Applied Chemistry 12(2):1682-1691
    CrossRef
  28. Wu YR, Choi HJ, Kang YG, Kim JK, Shin JW (2017) In vitro study on anti-inflammatory effects of epigallocatechin-3-gallate-loaded nano- and microscale particles. International Journal of Nanomedicine 2017:7007-7013. DOI https://doi.org/10.2147/IJN.S146296
    Pubmed KoreaMed CrossRef
  29. Ye Q, Wang B, Mao J (2020) The pathogenesis and treatment of the 'cytokine storm' in COVID-19. Journal of Infection 80:607-613
    Pubmed KoreaMed CrossRef
  30. Zabetakis I, Lordan R, Tsoupras CNA (2020) COVID-19: The Inflammation Link and the Role of Nutrition in Potential Mitigation. Nutrients 12(1466). doi:10.3390/nu1205146
    Pubmed KoreaMed CrossRef
  31. Zanatta L, Rosso Â, Folador P, Figueiredo MSRB, Pizzolatti MG, Leite LD, Silva FRMB (2008) Insulinomimetic effect of kaempferol 3-neohesperidoside on the rat soleus muscle. J Nat Prod 71(4):532-535
    Pubmed CrossRef

Article

Research Article

J Plant Biotechnol 2023; 50(1): 27-33

Published online March 29, 2023 https://doi.org/10.5010/JPB.2023.50.004.027

Copyright © The Korean Society of Plant Biotechnology.

UHPLC/TOFHRMS analysis and anti-inflammatory effect of leaf extracts from Zizyphus jujuba in LPS-stimulated RAW264.7 cells

Hyun Ji Eo ･Sun-Young Lee ･Gwang Hun Park

Special Forest Resources Division, Department of Forest Bio-Resources, National Institute of Forest Science, Suwon 16631, Korea
Forest Medicinal Resources Research Center, National Institute of Forest Science, Yeongju 36040, Korea
Forest Medicinal Resources Research Center, National Institute of Forest Science, Yeongju 36040, Korea

Correspondence to:e-mail: ppkh0230@korea.kr

Received: 1 November 2022; Revised: 9 February 2023; Accepted: 10 February 2023

This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Zizyphus jujube is a plant in the buckthorn family (Rhamnaceae) that has been the subject of research into antibacterial, antifungal and anti-inflammatory properties of its fruit and seed. However, few studies have investigated its leaves. In this study, the anti-inflammatory activity of ZJL (an extract of Z. jujube leaf) was evaluated to verify its potential as an anti-inflammatory agent and SARS-CoV-2 medicine, using nitric oxide (NO) assay, RT-PCR, SDS-PAGE, Western blotting, and UHPLC/TOFHRMS analysis. We found that ZJL suppresed pro-inflammatory mediators such as NO, inducible nitric oxide synthase (iNOS), cyclooxy-genase-2 (COX-2), and tumor necrosis factor α (TNF-α) in lipopolysaccharide (LPS)-induced RAW264.7 cells. ZJL acted by inhibiting NF-KB and MAPK signaling pathway activity. We also confirmed that ZJL contains a phenol compound and flavonoids with anti-inflammatory activity such as trehalose, maleate, epigallocatechin, hyperoside, catechin, 3-O-coumaroylquinic acid, rhoifolin, gossypin, kaempferol 3-neohesperidoside, rutin, myricitrin, guaiaverin, quercitrin, quercetin, ursolic acid, and pheophorbide a. These findings suggest that ZJL may have great potential for the development of anti-inflammatory drugs and vaccines via inhibition of NF‐ĸB and MAPK signaling in LPS-induced RAW264.7 cells.

Keywords: Anti-inflammation, MAPK, NF-κB, UHPLC/TOFHRMS, Ziziphus jujuba

Introduction

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) first emerged in Wuhan, China in December 2019. It is a type of highly pathogenic human coronavirus (HCoV) that poses a major threat to public health and causes disease in animals. Most coronavirus disease 2019 (COVID-19) patients had a good prognosis, but there were still some serious illnesses and deaths. One of the key features of COVID-19 is excessive inflammation observed in some patients, particularly those with severe illness. An exaggerated immune response mediated by a series of cytokines plays a key role in the development of disease. Studies have reported that several types of inflammatory mediators and immune cells are involved in the disease process (Saeedi-Boroujeni and Mahmoudian-Sani 2021; Zabetakis et al. 2020). The health status of our industrial population is at risk due to numerous inflammatory chronic diseases characterized by widespread and potentially low-grade inflammation. Therefore, researchers around the world have explored several anti-inflammatory and other pharmacological treatments to combat deadly inflammation (Tasinov et al. 2021; Tay et al. 2020).

Zizyphus jujuba Mill is one of the most important plants of the Rhamnaceae family (Ghani et al. 2022). Z. jujuba is a small deciduous tree that occurs naturally in Europe, East Asia and Australia. Many studies have been reported on jujube fruit and seed preparations that have been stimulated by their long-term use in Chinese and Korean traditional medicine for their antibacterial, antifungal, anti-inflammatory, antioxidant activity and anticancer properties (Damiano et al. 2017). Z. jujuba contains a wide range of constituents, including flavonoids such as quercetin, rutin, isoquercitrin, nicotiflorine and kaempferol, phenolic acid, triterepenoic acid and amino acids (Hong et al. 2015; Lee et al. 2004; Lee et al. 2016).

In this study, we evaluated the anti-inflammatory effect of Z. jujuba leaf in LPS-induced RAW264.7 cells and identified the regulatory mechanisms of NF-κB (nuclear factor kappa B) and MAPK (mitogen activated protein kinase) as molecular targets. In addition, by analyzing the components of Z. jujuba leaf, we tried to evaluate the possibility of using them as anti-inflammatory agents.

Materials and Methods

Materials

As a medium for culturing mouse macrophages (RAW264.7 cells), Dulbecco’s Modified Eagle’s medium (DMEM) was purchased from Lonza (Walkersville, MD, USA). Griess reagent used for detection and quantification of nitrite and nitrite ion and Thiazolyl Blue Tetrazolium Blue (MTT) for cytotoxicity evaluation and lipopolysaccharide (LPS) for anti-inflammatory evaluation were purchased from Sigma-Aldrich (St. Louis, MO, USA). Antibodies for western blot were purchased from Cell Signaling Technology (Danvers, MA, USA).

Preparation of extracts

Z. jujuba leaf (ZJL) was collected in June 2019 in Andong-si, Gyeongsangbuk-do, Korea, and were identified by Professor Jeong Kyu-young, Andong University (voucher number. FMRC-2190621A1). 20 g of freeze-dried ZJL was extracted with 100 mL of 70% ethanol (70% EtOH) for 48 hours while stirring at room temperature. After 48 hours, the 70% EtOH extract was filtered, concentrated using a vacuum evaporator (N-1000, EYELA, Tokyo, Japan), and then freeze-dried (recovery rate after sample extraction: 55.6 ± 4.1%). ZJL extract was dissolved in dimethyl sulfoxide (DMSO) and used in the experiments.

Cell culture

RAW264.7 cells were adopted from the American Type Culture Collection (ATCC, Virginia, USA). RAW264.7 cells were cultured in DMEM medium supplemented with 10% fetal bovine serum (FBS) at 37°C and 5% CO2. Cells were treated with ZJL dissolved in DMSO used as a vehicle at a final concentration of less than 0.1% (v/v).

MTT assay

RAW264.7 cells (1 × 106 cells/well) cultured in a 12-well plate were treated with ZJL for 24 hours. After 24 hours, 200 μL of MTT solution (1 mg/mL) was added and incubated for 2 hours. After 2 hours, the medium was removed and DMSO was added to the cells. The absorbance of the solution dissolved by DMSO was measured at 570 nm using a UV/visible spectrophotometer (Perkin Elmer, Norwolk, CT, USA).

Nitric oxide (NO) assay

RAW264.7 cells cultured in a 12-well plate (1 × 106 cells/well) for 24 hours were pretreated with ZJL for 6 hours. After 6 hours, RAW264.7 cells were co-treated with LPS (1 μg/mL) for 18 hours to induce an inflammatory response. After 18 hours, 50 μL of cell medium and 50 μL of Griess reagent were mixed in a 1:1 ratio. After reacting at room temperature for 10 minutes, absorbance was measured with a UV/Visible spectrophotometer 540 nm (Perkin Elmer, Norwalk, Connecticut, USA).

Sodium Dodecyl Sulfate-Poly Acrylamide Gel Electrophoresis (SDS-PAGE) and Western blot

After the experiment, RAW264.7 cells were harvested after washing three times with cold 1X phosphate buffered saline (1XPBS). RAW264.7 cells were lysed in 1X radioimmunoprecipitation assay (RIPA) buffer (Cell signaling, Bervely, MA, USA) and centrifuged at 15,000 rpm for 10 minutes at 4°C. Cellular protein was quantified using BCA protein assay (Thermo Fisher Scientific, Waltham, MA USA). Proteins separated by SDS-PAGE were transferred to a nitrocellulose membrane (Bio-Rad, CA, USA). After 1 hour of blocking (5% skim milk), the membrane was treated with primary antibody (1:1000) overnight. After overnight, they were washed three times with 0.05% Tween 20 and treated with secondary antibody (1:200) for 1 hour at room temperature. After ECL Western blotting was applied to the membrane, it was analyzed using the Chemi Doc MP Imaging system (Bio-rad, CA, USA).

Reverse transcriptase-polymerase chain reaction (RT-PCR)

RNeasy Mini Kit (Qiagen, Valencia, CA, USA) was used to extract total RNA from RAW264.7 cells after the experiment. To synthesize cDNA, 1 μg of total RNA was processed with the Verso cDNA synthesis kit. After cDNA synthesis, PCR was performed using a PCR master mix kit (Promega Co., Madison, WI, USA). Primers used for PCR (mouse iNOS, mouse COX-2, mouse TNF-α and mouse GAPDH) are listed in Table 1.

Table 1 . Sequences of oligonucleotide primers used for RT-PCR.

NO.Gene nameSequence
1iNOSForward 5′-GTG CTG CCT CTG GTC TTG CAA GC-3′
Reverse 5′-AGG GGC AGG CTG GGA ATT CG-3′
2COX-2Forward 5′-GGA GAG ACT ATC AAG ATA GTG ATC -3′
Reverse 5′-ATG GTC AGT AGA CTT TTA CAG CTC -3′
3TNF-αForward 5’-TAC TGA ACT TCG GGG TGA TTG GTC C-3’
Reverse 5’-CAG CCT TGT CCC TTG AAG AGA ACC-3’
4GAPDHForward 5′-CAG GAG CGA GAC CCC ACT AAC AT-3′
Reverse 5′-GTC AGA TCC ACG ACG GAC ACA TT-3′


Ultra-high performance liquid-chromatography/time-of-flight high-resolution mass spectrometry (UHPLC/TOFHRMS) analysis

UHPLC instrument (Therom Dionex, USA) equipped with a Waters Cortect C18 (2.1 mm × 150 mm, 1.8 μm, Water, USA) column was used. 0.1% Formic acid in water (A) and 0.1% Formic acid in acetonitrile (B) were used as mobile phase at a flow rate of 0.3 mL/min. The system was run with the following gradient program: 1% B for 1 min, 1%-30% B for 1-13 min, 21%-100% B for 13-21 min, maintained until the 24th min, 100%-1% B for 24-25 min, and maintained until the 30 min. The temperature of the column was maintained at 45 °C, and the injection volume was 3 μL.

Statistical analysis

All results were expressed as mean ± standard deviation after repeated measurements three times, and significance between treatments was verified by Student’s t-test. When p-value < 0.05, it was determined to be statistically significant.

Results and Discussion

The effect of ZJL on NO production and cytokines expression in LPS-stimulated RAW264.7 cells

COVID-19 infection is associated with an aggressive inflammatory response that releases large amounts of proinflammatory cytokines in an event known as a “cytokine storm.” The host immune response to the SARS-CoV-2 virus is hyperactive, resulting in an excessive inflammatory response (Ragab et al. 2020). Therefore, suppression of excessive cytokines such as iNOS, COX-2, and TNF-α is the key to anti-inflammatory effect. The effect of ZJL on the inhibition of NO production in LPS-induced RAW264.7 cells was investigated. MTT assay showed that ZJL (0, 12.5, 25, 50 μg/ml) was not toxic to RAW264.7 cells (Fig. 1A). As shown in Fig. 1B, ZJL reduced LPS-induced excessive production of NO in RAW264.7 cells in a concentration dependent manner (0, 12.5, 25, 50 μg/ml). Therefore, macrophages are RAW264.7 cells stimulated with LPS to confirm the inhibitory activity of inflammatory mediator gene expression, such as iNOS, COX-2, and TNF-α, which are known to be involved in the pathogenesis of inflammatory diseases. In Fig. 1C, it was confirmed that ZJL decreased the expression of iNOS, COX-2 and TNF-α in a concentration-dependent manner as affecting the expression of inflammatory derivatives. From these results, it was confirmed that ZJL can exhibit anti-inflammatory activity.

Figure 1. Effect of ZJL on the NO production of pro-inflammatory mediators such as iNOS, COX-2 and TNF-α in LPS-stimulated RAW264.7 cells. (A) RAW264.7 cells were treated with 25, 50, 100 μg/ml of ZJL for 24 hours, then an MTT assay was performed. (B) RAW264.7 cells were pretreated with 25, 50, 100 μg/ml of ZJL for 6 hours, then co-treated with 1 μg/mL of LPS for 18 hours, and then a Griess assay was performed. (C) RT-PCR analysis of total RNA. GAPDH was used as an internal control. *: significant difference (P < 0.05) to cells without ZJL

Effect of ZJL on NF-κB signaling activation in LPS-stimulated RAW264.7 cells

The basic mechanism of NF-κB activation is the inducible degradation of IκBα triggered by the multisubunit IκB kinase (IKK) complex. IKKs can be activated by cytokines, mitogens, microbial components, growth factors and infectious agents. Upon stimulation, NF-κB induces the expression of various pro-inflammatory cytokine genes. These pro-inflammatory cytokines further activate NF-κB signaling in an autocrine manner. SARS-CoV-2 appears to activate NF-κB and produce proinflammatory cytokines that correlate with mechanisms of COVID-19 pathogenesis. Because pro-inflammatory cytokines are elevated in patients with severe COVID-19. Indeed, NF-κB is activated in SARS-CoV-2 infected cells (Kircheis et al. 2020; Su et al. 2021). Therefore, in order to examine the effect of ZJL on the inhibition of NF-κB activity, it was confirmed that when LPS-derived RAW264.7 cells were treated with ZJL, IκB phosphorylation and degradation were inhibited in a concentration-dependent manner (Fig. 2A and B). As shown in 2C, it was confirmed that ZJL inhibits nuclear translocation of p65. These results suggest that ZJL has an anti-inflammatory effect by inhibiting NF-κB activity.

Figure 2. Effects of ZJL on NF-κB signaling activation in LPS-stimulated RAW264.7 cells. (A, B) RAW264.7 cells were pretreated with ZJL (0, 25, 50 μg/mL) for 6 hours and then co-treated with LPS (1 μg/mL) for 40 min. (C) RAW264.7 cells were pre-treated with ZJL (0, 25, 50 μg/mL) for 40 min. After the treatment, the cytosol and nucleus were prepared. For Western blot analysis, cell lysates were subjected to SDS-PAGE and the Western blot was performed using antibodies against IκB-α, p-IκB-α and nucleus p65. β-actin was used as an internal control. #: signficant difference (P < 0.05) to cells without treatment; *: significant difference (P < 0.05) to cells treated with LPS only

Effect of ZJL on MAPKs signaling activation in LPS-stimulated RAW264.7 cells

Several investigations have concluded that SARS-CoV-2 is a major factor in the increased cytokine inflammatory response associated with COVID-19 through activation of MAPK/NF-κB signaling. Elevated MAPKs signaling pathways including proteins such as extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK) and p38 control p65/NF-activation for cytokine production (Hariharan et al. 2021; Sharma et al. 2022; Ye et al. 2020). We investigated whether ZJL inhibits phosphorylation of ERK1/2, p38 or JNK, elucidating the inhibitory effect of ZJL on MAPKs signaling activation in LPS-induced RAW264.7 cells. Phosphorylation of ERK1/2 was inhibited in a concentration dependent manner (Fig. 3A). As shown in Fig. 3B, it was confirmed that ZJL inhibits p38 phosphorylation. JNK phosphorylation was inhibited in a concentration-dependent manner (12.5, 25, and 50 μg/ml). ZJL demonstrated anti-inflammatory potential in LPS-induced RAW264.7 cells by downregulating the MAPKs signaling pathway.

Figure 3. Effects of ZJL on MAPKs signaling activation in LPS-stimulated RAW264.7 cells. RAW264.7 cells were pretreated with ZJL (0, 25, 50 μg/mL) for 6 h and then co-treated with LPS (1 μg/mL) for 40 min. For Western blot analysis, the cell lysates were subjected to SDS-PAGE and the Western blot was performed using antibodies against p-p38, p-ERK1/2, and p-JNK. #: significant difference (P < 0.05) to cells without treatment; *: significant difference (P < 0.05) to cells treated with LPS only

HUPLC/TOFHRMS analysis of anti-inflammatory compounds in ZJL

To analyze the bioactive compounds with anti-inflammatory activity from ZJL, we performed HUPLC/TOFHRMS analysis. As shown in Table 2, ZJL was analyzed to contain compounds such as trehalose (Echigo et al. 2012), maleate (Vijeesh et al. 2022), epigallocatechin (Wu et al. 2017), hyperoside (Kim et al. 2011), catechin (Fan et al. 2017; Kim and Heo, 2022), 3-O-coumaroylquinic acid, rhoifolin (Eldahshan and Azab, 2012; Peng et al. 2020), gossypin (Cinar et al. 2019), kaempferol 3-neohesperidoside (Zanatta et al. 2008), rutin (Guardia et al. 2001), myricitrin (Domitrović et al. 2015), guaiaverin (Comalada et al. 2005; Tasinov et al. 2021), quercitrin (Lee et al. 2016), quercetin (Tang et al. 2019), ursolic acid (Checker et al. 2012) and phephorbide a (Nakamura et al. 1996) by UHPLC/MSMS. The compounds have been reported to anti-inflammatory activity.

Table 2 . Results of UHPLC/HRMS analysis of 16 functional components in ZJL.

NO.Retention time (min)ChemicalMolecular formulaMolecular weight
11.16TrehaloseC12H14O6342.1
21.2MaleateC4H4O4116
36.85EpigallocatechinC15H14O7306.1
46.93HyperosideC21H20O12464.1
57.14CatechinC15H14O6290.1
68.493-O-Coumaroylquinic acidC16H18O8338.1
78.5RhoifolinC27H30O14578.2
89.59GossypinC21H20O13480.1
910.11Kaempferol 3-neohesperidosideC27H30O1510.11
1010.37RutinC27H30O16610.2
1110.47MyricitrinC21H20O12464.1
1211.22GuaiaverinC20H18O11434.1
1311.67QuercitrinC21H20O11448.1
1414.19QuercetinC15H10O7302
1521.78Ursolic acidC30H48O3456.4
1622.58Pheophorbide aC35H36N4592.3


In conclusion, these results suggest that ZJL can be used as an alternative supplement for anti-inflammatory and COVID-19 treatment (vaccine). Isolation of anti-inflammatory substances and identification of mechanisms are considered necessary in the future.

Acknowledgement

This work was supported by a grant from National Institute of Forest Science (project number: FP0400-2019-01-2022).

Fig 1.

Download
Figure 1.Effect of ZJL on the NO production of pro-inflammatory mediators such as iNOS, COX-2 and TNF-α in LPS-stimulated RAW264.7 cells. (A) RAW264.7 cells were treated with 25, 50, 100 μg/ml of ZJL for 24 hours, then an MTT assay was performed. (B) RAW264.7 cells were pretreated with 25, 50, 100 μg/ml of ZJL for 6 hours, then co-treated with 1 μg/mL of LPS for 18 hours, and then a Griess assay was performed. (C) RT-PCR analysis of total RNA. GAPDH was used as an internal control. *: significant difference (P < 0.05) to cells without ZJL
Journal of Plant Biotechnology 2023; 50: 27-33https://doi.org/10.5010/JPB.2023.50.004.027

Fig 2.

Download
Figure 2.Effects of ZJL on NF-κB signaling activation in LPS-stimulated RAW264.7 cells. (A, B) RAW264.7 cells were pretreated with ZJL (0, 25, 50 μg/mL) for 6 hours and then co-treated with LPS (1 μg/mL) for 40 min. (C) RAW264.7 cells were pre-treated with ZJL (0, 25, 50 μg/mL) for 40 min. After the treatment, the cytosol and nucleus were prepared. For Western blot analysis, cell lysates were subjected to SDS-PAGE and the Western blot was performed using antibodies against IκB-α, p-IκB-α and nucleus p65. β-actin was used as an internal control. #: signficant difference (P < 0.05) to cells without treatment; *: significant difference (P < 0.05) to cells treated with LPS only
Journal of Plant Biotechnology 2023; 50: 27-33https://doi.org/10.5010/JPB.2023.50.004.027

Fig 3.

Download
Figure 3.Effects of ZJL on MAPKs signaling activation in LPS-stimulated RAW264.7 cells. RAW264.7 cells were pretreated with ZJL (0, 25, 50 μg/mL) for 6 h and then co-treated with LPS (1 μg/mL) for 40 min. For Western blot analysis, the cell lysates were subjected to SDS-PAGE and the Western blot was performed using antibodies against p-p38, p-ERK1/2, and p-JNK. #: significant difference (P < 0.05) to cells without treatment; *: significant difference (P < 0.05) to cells treated with LPS only
Journal of Plant Biotechnology 2023; 50: 27-33https://doi.org/10.5010/JPB.2023.50.004.027

Table 1 . Sequences of oligonucleotide primers used for RT-PCR.

NO.Gene nameSequence
1iNOSForward 5′-GTG CTG CCT CTG GTC TTG CAA GC-3′
Reverse 5′-AGG GGC AGG CTG GGA ATT CG-3′
2COX-2Forward 5′-GGA GAG ACT ATC AAG ATA GTG ATC -3′
Reverse 5′-ATG GTC AGT AGA CTT TTA CAG CTC -3′
3TNF-αForward 5’-TAC TGA ACT TCG GGG TGA TTG GTC C-3’
Reverse 5’-CAG CCT TGT CCC TTG AAG AGA ACC-3’
4GAPDHForward 5′-CAG GAG CGA GAC CCC ACT AAC AT-3′
Reverse 5′-GTC AGA TCC ACG ACG GAC ACA TT-3′

Table 2 . Results of UHPLC/HRMS analysis of 16 functional components in ZJL.

NO.Retention time (min)ChemicalMolecular formulaMolecular weight
11.16TrehaloseC12H14O6342.1
21.2MaleateC4H4O4116
36.85EpigallocatechinC15H14O7306.1
46.93HyperosideC21H20O12464.1
57.14CatechinC15H14O6290.1
68.493-O-Coumaroylquinic acidC16H18O8338.1
78.5RhoifolinC27H30O14578.2
89.59GossypinC21H20O13480.1
910.11Kaempferol 3-neohesperidosideC27H30O1510.11
1010.37RutinC27H30O16610.2
1110.47MyricitrinC21H20O12464.1
1211.22GuaiaverinC20H18O11434.1
1311.67QuercitrinC21H20O11448.1
1414.19QuercetinC15H10O7302
1521.78Ursolic acidC30H48O3456.4
1622.58Pheophorbide aC35H36N4592.3

References

  1. Checker R, Sandur SK, Sharma D, Patwardhan RS, Jayakumar S, Kohli V, Sethi G, Aggarwal BB, Sainis KB (2012) Potent Anti-Inflammatory Activity of Ursolic Acid, a Triterpenoid Antioxidant, Is Mediated through Suppression of NF-κB, AP-1 and NF-AT. PLOS ONE 7(2):e31318. https://doi.org/10.1371/journal.pone.0031318
    Pubmed KoreaMed CrossRef
  2. Cinar I, Sirin B, Aydin P, Toktay E, Cadirci E, Halici I, Halici Z (2019) Ameliorative effect of gossypin against acute lung injury in experimental sepsis model of rats. Life Sci 221:327-334. doi: 10.1016/j.lfs.2019.02.039
    Pubmed CrossRef
  3. Comalada M, Camuesco D, Sierra S, Ballester I, Xaus J, Gálvez J, Zarzuelo A (2005) In vivo quercitrin anti-inflammatory effect involves release of quercetin, which inhibits inflammation through down-regulation of the NF-kappaB pathway. Eur J Immunol 35(2):584-592. doi: 10.1002/eji.200425778
    Pubmed CrossRef
  4. Damiano S, Forino M, De A, Vitali LA, Lupidi G, Taglialatela-Scafati O (2017) Antioxidant and antibiofilm activities of secondary metabolites from Ziziphus jujuba leaves used for infusion preparation. Food Chemistry 230:24-29
    Pubmed CrossRef
  5. Domitrović R, Rashed K, Cvijanović O, Vladimir-Knežević S, Škoda M, Višnić A (2015) Myricitrin exhibits antioxidant, anti-inflammatory and antifibrotic activity in carbon tetrachloride-intoxicated mice. Chem Biol Interact 230:21-29. doi: 10.1016/j.cbi.2015.01.030
    Pubmed CrossRef
  6. Echigo R, Shimohata N, Karatsu K, Yano F, Kayasuga-Kariya Y, Fujisawa A, Ohto T, Kita Y, Nakamura M, Suzuki S, Mochizuki M, Shimizu T, Chung UI, Sasaki N (2012) Trehalose treatment suppresses inflammation, oxidative stress, and vasospasm induced by experimental subarachnoid hemorrhage. J Transl Med 10:80. doi: 10.1186/1479-5876-10-80
    Pubmed KoreaMed CrossRef
  7. Eldahshan OA, Azab SS (2012) Anti-inflammatory Effect of Apigenin-7-neohesperidoside (Rhoifolin) in Carrageenin-Induced Rat Oedema Model. Journal of Applied Pharmaceutical Science 2(8):74-79. doi: 10.7324/JAPS.2012.2811
    CrossRef
  8. Fan FY, Sang LX, Jiang M (2017) Catechins and Their Therapeutic Benefits to Inflammatory Bowel Disease. Molecules 22(3):484. doi: 10.3390/molecules22030484
    Pubmed KoreaMed CrossRef
  9. Ghani A, Amini S, Mohtashami S, Neamati SH (2022) Physicochemical and biochemical variations of jujube (Ziziphus jujuba Mill.) populations: A comparison of Iranian and imported types. Industrial Crops & Products 183:114898
    CrossRef
  10. Guardia T, Rotelli AE, Juarez AO, Pelzer LE (2001) Anti-inflammatory properties of plant flavonoids. Effects of rutin, quercetin and hesperidin on adjuvant arthritis in rat. Il Farmaco 56(9):683-687. https://doi.org/10.1016/S0014-827X(01)01111-9
    Pubmed CrossRef
  11. Hariharan A, Hakeem AR, Radhakrishnan S, Reddy MS, Rela M (2021) The role and therapeutic potential of nf-kappa-b pathway in severe COVID-19 patients. Inflammopharmacology 29:91-100. DOI: 10.1007/s10787-020-00773-9
    Pubmed KoreaMed CrossRef
  12. Hong EH, Song JH, Kang KB, Sung SH, Ko HJ, Yang HJ (2015) Anti-Influenza Activity of Betulinic Acid from Zizyphus jujuba on Influenza A/PR/8 Virus. Biomolecules & Therapeutics 23(4):345-349
    CrossRef
  13. Kim JM, Heo HJ (2022) The roles of catechins in regulation of systemic inflammation. Food Sci Biotechnol. https://doi.org/10.1007/s10068-022-01069-0
    Pubmed KoreaMed CrossRef
  14. Kim SJ, Um JY, Lee JY (2011) Anti-inflammatory activity of hyperoside through the suppression of nuclear factor-κB activation in mouse peritoneal macrophages. Am J Chin Med 39(1):171-181. DOI: 10.1142/S0192415X11008737
    Pubmed CrossRef
  15. Kircheis R, Haasbach E, Lueftenegger D, Heyken WT, Ocker M, Planz O (2020) KNF-κB Pathway as a Potential Target for Treatment of Critical Stage COVID-19 Patients. Front Immunol 11:598444. https://doi.org/10.3389/fimmu.2020.598444
    Pubmed KoreaMed CrossRef
  16. Lee JS, Choi JW, Sohng JK, Pandey RP, Park YI (2016) The immunostimulating activity of quercetin 3-O-xyloside in murine macrophages via activation of the ASK1/MAPK/NF-κB signaling pathway. International Immunopharmacology 31:88-97
    Pubmed CrossRef
  17. Lee SM, Park JG, Lee YH, Lee CG, Min BS, Kim JH, Lee HK (2004) Anti-complementary Activity of Triterpenoides from Fruits of Zizyphus jujuba. Biol Pharm Bull 27(11):1883-1886
    Pubmed CrossRef
  18. Nakamura Y, Murakami A, Koshimizu K, Ohigashi H (1996) Inhibitory effect of pheophorbide a, a chlorophyll-related compound, on skin tumor promotion in ICR mouse. Cancer Letters 108(2):247-255
    CrossRef
  19. Peng S, Hu C, Liu X, Lei L, He G, Xiong C, Wu W (2020) Rhoifolin regulates oxidative stress and proinflammatory cytokine levels in Freund's adjuvant-induced rheumatoid arthritis via inhibition of NF-κB. Braz J Med Biol Res 53(6):9489. doi: 10.1590/1414-431X20209489
    Pubmed KoreaMed CrossRef
  20. Ragab D, Eldin HS, Taeimah M, Khattab R, Salem R (2020) The COVID-19 Cytokine Storm; What We Know So Far. Frontiers in Immunology 11:1446. https://doi.org/10.3389/fimmu.2020.01446
    Pubmed KoreaMed CrossRef
  21. Saeedi-Boroujeni A, Mahmoudian-Sani MR (2021) Anti-inflammatory potential of Quercetin in COVID-19 treatment. Journal of Inflammation 18(3):1-9
    Pubmed KoreaMed CrossRef
  22. Sharma VK, Prateeksha, Singh SP, Singh BN, Rao CV, Barik SK (2022) Nanocurcumin Potently Inhibits SARS-CoV-2 Spike Protein-Induced Cytokine Storm by Deactivation of MAPK/NF-κB Signaling in Epithelial Cells. ACS Appl Bio Mater 5(2):483-491. https://doi.org/10.1021/acsabm.1c00874
    Pubmed KoreaMed CrossRef
  23. Su CM, Wang L, Yoo D (2021) Activation of NF-κB and induction of proinflammatory cytokine expressions mediated by ORF7a protein of SARS-CoV-2. scientific reports 11:13464. https://doi.org/10.1038/s41598-021-92941-2
    Pubmed KoreaMed CrossRef
  24. Tang J, Diao P, Shu X, Li L, Xiong L (2019) Quercetin and Quercitrin Attenuates the Inflammatory Response and Oxidative Stress in LPS-Induced RAW264.7 Cells: In Vitro Assessment and a Theoretical Model. BioMed Research International 2019:7039802. https://doi.org/10.1155/2019/7039802
    Pubmed KoreaMed CrossRef
  25. Tasinov O, Dincheva I, Badjakov I, Kiselova-Kaneva Y, Galunska B, Nogueiras R, Ivanova D (2021) Phytochemical Composition, Anti-Inflammatory and ER Stress-Reducing Potential of Sambucus ebulus L. Fruit Extract Plants (Basel) 10(11):2446. doi: 10.3390/plants10112446
    Pubmed KoreaMed CrossRef
  26. Tay M, Poh C, Renia L, MacAry P, Ng L (2020) The trinity of COVID-19: Immunity, inflammation and intervention. Nature Reviews Immunology 20:363-374
    Pubmed KoreaMed CrossRef
  27. Vijeesh V, Vysakh A, Jisha N, Latha MS (2022) Malic Acid Attenuates Potassium Oxonate Induced Gouty Inflammation in Wistar Rat. Biointerface Research in Applied Chemistry 12(2):1682-1691
    CrossRef
  28. Wu YR, Choi HJ, Kang YG, Kim JK, Shin JW (2017) In vitro study on anti-inflammatory effects of epigallocatechin-3-gallate-loaded nano- and microscale particles. International Journal of Nanomedicine 2017:7007-7013. DOI https://doi.org/10.2147/IJN.S146296
    Pubmed KoreaMed CrossRef
  29. Ye Q, Wang B, Mao J (2020) The pathogenesis and treatment of the 'cytokine storm' in COVID-19. Journal of Infection 80:607-613
    Pubmed KoreaMed CrossRef
  30. Zabetakis I, Lordan R, Tsoupras CNA (2020) COVID-19: The Inflammation Link and the Role of Nutrition in Potential Mitigation. Nutrients 12(1466). doi:10.3390/nu1205146
    Pubmed KoreaMed CrossRef
  31. Zanatta L, Rosso Â, Folador P, Figueiredo MSRB, Pizzolatti MG, Leite LD, Silva FRMB (2008) Insulinomimetic effect of kaempferol 3-neohesperidoside on the rat soleus muscle. J Nat Prod 71(4):532-535
    Pubmed CrossRef
JPB
Vol 51. 2024
Current Issue Archives

Stats or Metrics

Share this article on

  • line

Related articles in JPB

Journal of

Plant Biotechnology

pISSN 1229-2818
eISSN 2384-1397
qr-code Download